Position
StepStone Group LP in Entrada Therapeutics, Inc.
Back to the book · All holders of TRDA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.78M$10.28 → $12.62
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 761.3K | $7.83M | — | — | — | 4.2% |
| Q1 2026 | 761.3K | $9.61M | $12.62 | $1.78M | $0 | 4.6% |